Showing 3651-3660 of 18633 results for "".
Keeping Up on Matters 'Down There:' Feminine Hygiene Advice for Clinicians
https://reachmd.com/programs/sexmed/keeping-up-matters-down-there-feminine-hygiene-advice-clinicians/8151/Dr. Alyssa Dweck imparts essential tips for clinicians to talk to patients about feminine hygiene.Low Libido in Women: Ending the Conspiracy of Silence
https://reachmd.com/programs/sexmed/low-libido-women-ending-conspiracy-silence/7942/Patient advocate Amanda Parrish talks about hypoactive sexual desire disorder in women, and the conspiracy of silence around recognizing this issue.When Disaster Strikes: Challenges in Securing Funds for Disaster Medicine
https://reachmd.com/programs/the-pulse-of-emergency-medicine/when-disaster-strikes-challenges-securing-funds-disaster-medicine/8044/talks about challenges of securing funding for disaster relief in emergency medicine, and the integration of citizen volunteers in disaster incidents.Meningitis Education and Prevention: Beyond the Headlines
https://reachmd.com/programs/clinicians-roundtable/Meningitis-Education-Prevention-Beyond-Headlines/8068/Lynn Bozof, cofounder and President of the National Meningitis Association, discusses ongoing efforts to increase awareness for this disease.Toward a Family-Centered Approach to Cesarean Deliveries
https://reachmd.com/programs/clinicians-roundtable/toward-family-centered-approach-cesarean-deliveries/7811/Cesarean sections are among the most common surgical procedures performed in the U.S. Yet despite its commonality, patients undergoing cesarean deliveries are far more likely to have difficult and unsatisfatcory birth experiences, leading to higher incidence rates of postpartum depression, bonding dFlibanserin 101: Benefits vs Risks for Women with Hypoactive Sexual Desire Disorder
https://reachmd.com/programs/sexmed/flibanserin-101-benefits-risks-women-hypoactive-sexual-desire-disorder/7679/Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne inHow to Best Answer "What is This Rash?"
https://reachmd.com/programs/primary-care-today/how-to-best-answer-what-is-this-rash/7652/Dr. Brian McDonough welcomes Dr. John Ely, Professor of Family Medicine at the University of Iowa Carver College of Medicine. Dr. Ely has written numerous articles addressing the top questions surfacing in general practice. He joins Primary Care Today to focus on perhaps the most common question askReconstructive Surgery for Pelvic Floor Disorders: Benefits vs Risks for Sexual Health
https://reachmd.com/programs/sexmed/reconstructive-surgery-pelvic-floor-disorders-benefits-vs-risks-sexual-health/7521/For women in their 40's and 50's, approximately one in four will develop a pelvic floor disorder such as urinary incontinence. By the age of 80, that prevalence rises to more than 50 percent. The struggle with a pelvic floor disorder has lasting effects on a woman's sexual health, leading to numerouLooking Back, Striving Forward: Novel Directions from Dr. Mark DeFrancesco, ACOG's 66th President
https://reachmd.com/programs/advances-in-womens-health/looking-back-striving-forward-novel-directions-dr-mark-defrancesco-acogs-66th-president/7487/Dr. Matt Birnholz welcomes Dr. Mark DeFrancesco, 66th President of The American College of Obstetricians and Gynecologists, to the program. Dr. DeFrancesco looks back at the accomplishments of his immediate predecessors, and reflects on the three-fold initiative to which he will dedicate his effortsThe National Drug Code Directory
https://reachmd.com/programs/FDA-Drug-Information-Updates/national-drug-code-directory/7462/The “NDC Directory” locates unique National Drug Codes for marketed products. It is a useful resource with searchable features and many added components for healthcare practitioners. FDA Drug Info Rounds pharmacists demonstrate how to use this quick, easy, online resource. Learn more of the FDA Drug